Analysis of Sustained Benefit of Vedolizumab Combined with 5-ASA in the Treatment of Active UC

The requested reference [9954b2d66af87d1d613f77a3e4fb7b433d3a3af9] no longer exists in our database. It has been replaced by the current reference: [80e8966b59ae29e096012faf2520f210fce22764]

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 3ad38b1eed6c0570ebb2ef80cbce6100be1cc04e
First added on: Oct 10, 2026